NIF3L1
NIF3-like protein 1
Also known as: ALS2CR1, CALS-7, MDS015, NIF3L_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZT8
- Gene
- NIF3L1
- Ensembl
- ENSG00000196290
- Chromosome
- 2
- Canonical length
- 377 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables RNA polymerase II-specific DNA-binding transcription factor binding activity and identical protein binding activity. Involved in positive regulation of DNA-templated transcription. Located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
377 residues, UniProt reviewed canonical sequence.
>Q9GZT8|NIF3L1
1 MLSSCVRPVP TTVRFVDSLI CNSSRSFMDL KALLSSLNDF ASLSFAESWD NVGLLVEPSP
61 PHTVNTLFLT NDLTEEVMEE VLQKKADLIL SYHPPIFRPM KRITWNTWKE RLVIRALENR
121 VGIYSPHTAY DAAPQGVNNW LAKGLGACTS RPIHPSKAPN YPTEGNHRVE FNVNYTQDLD
181 KVMSAVKGID GVSVTSFSAR TGNEEQTRIN LNCTQKALMQ VVDFLSRNKQ LYQKTEILSL
241 EKPLLLHTGM GRLCTLDESV SLATMIDRIK RHLKLSHIRL ALGVGRTLES QVKVVALCAG
301 SGSSVLQGVE ADLYLTGEMS HHDTLDAASQ GINVILCEHS NTERGFLSDL RDMLDSHLEN
361 KINIILSETD RDPLQVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NIF3L1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 30 nTPM
- retina: 30 nTPM
- tongue: 29 nTPM
- rectum: 26 nTPM
- parathyroid gland: 25 nTPM
- epididymis: 25 nTPM
Single-cell type
- oocytes: 106 nCPM
- retinal bipolar cells: 69 nCPM
- extravillous trophoblasts: 49 nCPM
- cytotrophoblasts: 48 nCPM
- migrating cytotrophoblasts: 46 nCPM
- differentiating spermatogonia: 43 nCPM
Immune cell
- basophil: 71 nTPM
- naive CD4 T-cell: 36 nTPM
- memory CD8 T-cell: 35 nTPM
- intermediate monocyte: 35 nTPM
- NK-cell: 34 nTPM
- T-reg: 32 nTPM
Brain region
- white matter: 24 nTPM
- cerebral cortex: 22 nTPM
- pons: 22 nTPM
- basal ganglia: 21 nTPM
- cerebellum: 20 nTPM
- spinal cord: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NIF3L1.
Disease | ImmuneIEDB
Conditions an epitope on NIF3L1 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.22
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- neuron differentiation
- positive regulation of DNA-templated transcription
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DUF34/NIF3
- DUF34/NIF3, animal
- DUF34/NIF3 superfamily
- Duf34/NIF3 (NGG1p interacting factor 3)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NIF3L1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NIF3L1 as an antibody target. Whether an autoantibody or antibody against NIF3L1 could matter depends on whether native NIF3L1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NIF3L1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NIF3L1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...